长非编码RNA中介于神经内分泌前列腺癌中对酶胺的抗性和转化
Zhe Zhu1, Wenjing Xuan2, Chaohui Wang3
1Department of Urology, Anhui No.2 Provincial People's Hospital, HeFei, China.
Frontiers in oncology
|December 10, 2024
概括
长非编码RNAs (lncRNAs) 是神经内分泌前列腺癌 (NEPC) 和对酶胺耐药性的关键参与者. 了解lncRNA的作用为晚期前列腺癌提供了新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 前列腺癌是一种异质的,耐药的恶性瘤.
- 神经内分泌前列腺癌 (NEPC) 驱动晚期耐药性.
- 恩扎胺是一种新型抗雄激素,用于治疗.
研究的目的:
- 阐明长非编码RNAs (lncRNAs) 在NEPC进化中的作用.
- 为了研究 lncRNA 参与酶胺耐药性的问题.
- 探索前列腺癌进展和治疗耐药性的lncRNA机制.
主要方法:
- 专注于调节酶胺耐药性和NEPC过渡的lncRNAs.
- 对表观遗传,雄激素受体 (AR) 信号和非AR通路的分析.
- 检查 lncRNAs 作为 miRNAs 的"分子海绵".
主要成果:
- lncRNAs显著影响NEPC的发展.
- lncRNAs通过各种途径调解对酶胺的抗性.
- lncRNA与miRNA相互作用,影响前列腺癌的进展.
结论:
- lncRNAs是前列腺癌神经内分泌分化和酶胺耐药性的关键调节者.
- 了解lncRNA功能提供了新的治疗点.
- 这项研究为克服晚期前列腺癌治疗阻力提供了新的方向.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K